Brief: BioAtla Q2 Net Income USD -21.072 Million
08/08/2024 21:05
Aug 08 (Reuters) - BioAtla Q2 operating expenses USD 21.972 million. * Q2 operating income USD -21.972 million
Recent news on Bioatla
See all newsBrief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM